Oncology Medical News about colorectal tumors;MLH1- and MSH2-deficient

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Reduced mRNA expression in paraffin-embedded tissue identifies MLH1- and MSH2-deficient colorectal tumours and potential mutation carriers
Virchows Archiv, 07/03/08

Müller A et al. - In a trial to identify MLH1 or MSH2-deficient colorectal tumours, it was found that RT-PCR allows relative quantification of MMR gene mRNA expression in formalin-fixed and paraffin-embedded tissue, and this approach enables quantification of haploinsufficiency due to nonsense-mediated mRNA decay in normal tissue and B-lymphocytes from pts carrying MSH2 germline mutations and may be useful for identification of asymptomatic carriers of pathogenic germline mutations

Methods

Based on the principle of nonsense-mediated mRNA decay, MLH1 or MSH2-deficient colorectal tumours were identified through relative quantification of mRNA expression with real-time PCR (RT-PCR) analysis

Results

MLH1 and MSH2 mRNAs were almost equally expressed as defined by MLH1 to MSH2 transcript ratio in 16 microsatellite stable, mismatch repair (MMR) proficient tumours
A close correlation between loss of protein expression and MMR–mRNA levels was found in highly microsatellite instable (MSI-H) tumours deficient of MLH1 or MSH2
MLH1/MSH2 ratio was low in 11 sporadic and 9 hereditary MLH1-deficient carcinomas, whereas the ratio was high in 17 MSH2-deficient hereditary non-polyposis colorectal cancer (HNPCC) associated carcinomas
In the normal tissues of HNPCC pts with MSH2 mutations, the MLH1/MSH2 transcript ratios were significantly elevated as compared with the ratios of normal mucosa in pts with MMR-proficient tumours
Analysis of B-lymphocytes of HNPCC pts with proven MMR gene mutation confirmed these findings

<< Previous
Evidence of poorer survival in pregnancy-associated breast cancer

Next >>
Overexpression of Pokemon in non-small cell lung cancer and...